Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Engineering tolerance into transplanted beta cell lines.

B Thorens1, P Dupraz, S Cottet

  • 1Institute of Pharmacology and Toxicology, University of Lausanne, Switzerland. Bernard.Thorens@ipharm.unil.ch

Annals of the New York Academy of Sciences
|January 19, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Taking the diet of cows into consideration in designing payments to reduce enteric methane emissions on dairy farms.

Journal of dairy science·2023
Same author

Review: Associations among goods, impacts and ecosystem services provided by livestock farming.

Animal : an international journal of animal bioscience·2018
Same author

Carbohydrates and insulin resistance in clinical nutrition: Recommendations from the ESPEN expert group.

Clinical nutrition (Edinburgh, Scotland)·2016
Same author

The Islet and Metabolism Keep Time.

Diabetes, obesity & metabolism·2015
Same author

The mind and the belly: a glance at how the nervous system directs metabolism.

Diabetes, obesity & metabolism·2014
Same author

Neural regulation of pancreatic islet cell mass and function.

Diabetes, obesity & metabolism·2014
Same journal

Multiomics Profiling During Autoimmune Demyelination Highlights a Complex Regulatory Role for Ataxin-1 in B Cells.

Annals of the New York Academy of Sciences·2026
Same journal

Global Trends in Light Pollution and Their Relationship With Socioeconomic Factors.

Annals of the New York Academy of Sciences·2026
Same journal

Wired for Corruption: Inter-Brain Synchrony Encodes Bribery-Related Value Information and Predicts Bribery Agreement.

Annals of the New York Academy of Sciences·2026
Same journal

LM-YOLO: A Lightweight Multi-Scale Enhanced Model for Forest Smoke Detection Using Unmanned Aerial Vehicles.

Annals of the New York Academy of Sciences·2026
Same journal

Polyrhythm Perception and Production: A Scoping Review.

Annals of the New York Academy of Sciences·2026
Same journal

DARTS-CNN-BiLSTM: Intelligent Fault Diagnosis for Computer Numerical Control Machine Tool Feed System.

Annals of the New York Academy of Sciences·2026
See all related articles

Genetic engineering can enhance insulin-producing cells for type 1 diabetes treatment. Transferring specific genes improves cell resistance to metabolic and inflammatory stresses, boosting survival in transplanted environments.

Area of Science:

  • Cell biology
  • Genetic engineering
  • Immunology

Background:

  • Transplanted insulin-secreting cells face metabolic and inflammatory challenges in type 1 diabetic environments.
  • Cellular stress limits the long-term function and survival of encapsulated pancreatic islets.

Purpose of the Study:

  • To investigate genetic engineering strategies for enhancing the resilience of insulin-secreting cells.
  • To improve the survival and function of transplanted cells in a type 1 diabetic setting.

Main Methods:

  • Utilizing genetic engineering techniques to modify insulin-secreting cells.
  • Introducing the Bcl-2 antiapoptotic gene to prevent cell death.
  • Implementing gene transfer to interfere with intracellular cytokine signaling pathways.

Related Experiment Videos

Main Results:

  • Demonstrated significant improvement in cellular resistance to metabolic stresses.
  • Showcased enhanced survival of genetically modified cells under inflammatory conditions.
  • Confirmed the efficacy of Bcl-2 gene transfer and cytokine pathway interference.

Conclusions:

  • Genetic modification, specifically with Bcl-2 and cytokine pathway interference genes, enhances insulin-secreting cell resistance.
  • These engineered cells show improved survival and function, offering potential for type 1 diabetes therapy.
  • The study highlights a promising approach for overcoming barriers in cell transplantation for diabetes treatment.